Semax
Synthetic heptapeptide derivative of ACTH(4-10). Studied in Russian literature on cerebrovascular and cognitive research models.
What the literature says.
Mechanism of action
Published literature describes upregulation of neurotrophic factors (BDNF, NGF) and modulation of the HPA axis without direct glucocorticoid activity. Additional reports cover dopaminergic and serotonergic system effects.
Preclinical summary
Semax is a 7-amino-acid peptide derived from the 4–10 fragment of adrenocorticotropic hormone (ACTH), with a Pro-Gly-Pro tail conferring enzymatic stability. Published studies cover BDNF/NGF expression and ischemia-model endpoints.
Safety
Research material only. Not a drug, supplement, or food product. No human or animal administration is supported or implied. Handling should follow the purchaser's institutional biosafety and chemical hygiene protocols.
Shipping & storage
Ships overnight in insulated packaging with ice packs when lab conditions require. Store lyophilized powder at 2–8°C. After reconstitution, store at 2–8°C and use within standard stability windows documented on the lot-specific Certificate of Analysis.
The compound, in numbers.
Research use only.
These products are intended for laboratory research purposes only and are not for human or animal consumption.
The statements on this website have not been evaluated by the U.S. Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.